Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Operating Expenses: 2018-2021

Historic Operating Expenses for Black Diamond Therapeutics (BDTX) over the last 4 years, with Dec 2021 value amounting to $126.9 million.

  • Black Diamond Therapeutics' Operating Expenses rose 12.50% to $26.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was $115.3 million, marking a year-over-year increase of 65.79%. This contributed to the annual value of $126.9 million for FY2021, which is 82.37% up from last year.
  • As of FY2021, Black Diamond Therapeutics' Operating Expenses stood at $126.9 million, which was up 82.37% from $69.6 million recorded in FY2020.
  • Over the past 5 years, Black Diamond Therapeutics' Operating Expenses peaked at $126.9 million during FY2021, and registered a low of $8.9 million during FY2018.
  • Moreover, its 3-year median value for Operating Expenses was $69.6 million (2020), whereas its average is $75.3 million.
  • Data for Black Diamond Therapeutics' Operating Expenses shows a peak YoY soared of 229.42% (in 2019) over the last 5 years.
  • Yearly analysis of 4 years shows Black Diamond Therapeutics' Operating Expenses stood at $8.9 million in 2018, then surged by 229.42% to $29.3 million in 2019, then surged by 137.18% to $69.6 million in 2020, then skyrocketed by 82.37% to $126.9 million in 2021.